DeepMed Research

RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Early Phase 1

Active, not recruiting

Conditions: Breast Cancer, Early-Onset

Interventions: Drug: Neoadjuvant chemotherapy administered before surgical extraction of a tumor
Other: Observational

First Posted Date: 2022-04-19

Last Posted Date: 2023-11-15

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 34

Registration Number: NCT05333874

Locations: 🇺🇸
Cooperman Barnabas Medical Center, Livingston, New Jersey, United States
🇺🇸
Newark Beth Israel Medical Center, Newark, New Jersey, United States
🇺🇸
Trinitas Hospital and Comprehensive Cancer Center, Elizabeth, New Jersey, United States

and more 9 locations

Reducing Pain From Wisdom Molar Extractions

Phase 2

Recruiting

Conditions: Acute Pain

Interventions: Drug: Temporo-masseteric Nerve Block

First Posted Date: 2022-04-19

Last Posted Date: 2024-12-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 20

Registration Number: NCT05335070

Locations: 🇺🇸
The University Hospital- Dental Clinic, Newark, New Jersey, United States

Study to Evaluate the Safety of Colchicine

Phase 1

Recruiting

Conditions: Radiation Therapy

Interventions: Drug: oral colchicine(0.6 mg) once a day

First Posted Date: 2022-04-19

Last Posted Date: 2023-11-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 30

Registration Number: NCT05335148

Locations: 🇺🇸
RWJBarnabas Health - Cooperman Barnabas, Livingston, New Jersey, United States
🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States
🇺🇸
Rutgers, The State University of New Jersey Board Contact:, New Brunswick, New Jersey, United States

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

Phase 2

Recruiting

Conditions: Gastro-Intestinal Cancer

Interventions: Drug: Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI)

First Posted Date: 2022-04-18

Last Posted Date: 2023-08-23

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 38

Registration Number: NCT05332002

Locations: 🇺🇸
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset, New Brunswick, New Jersey, United States
🇺🇸
RWJBarnabas Health - Newark Beth Israel Medical Center, Newark, New Jersey, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

and more 3 locations

Lean and Obese: Dietary Inflammation

Not Applicable

Completed

Conditions: Obesity
Inflammation
Dietary Fat

Interventions: Other: Low Fat Diet (LFD)
Other: High Fat Diet (HFD)

First Posted Date: 2022-04-14

Last Posted Date: 2024-03-25

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 32

Registration Number: NCT05327868

Locations: 🇺🇸
Rutgers University, New Brunswick, New Jersey, United States

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Not Applicable

Recruiting

Conditions: Pancreatic Ductal Adenocarcinoma

Interventions: Procedure: Biopsy
Procedure: Therapeutic Conventional Surgery
Other: Uniformly-labeled [13C]glucose

First Posted Date: 2022-03-25

Last Posted Date: 2024-04-10

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 16

Registration Number: NCT05296421

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Cooperman Barnabas Medical Center (Saint Barnabas Medical Center), Livingston, New Jersey, United States

Carbon Dioxide (CO2) and Cognitive Impairment

Not Applicable

Recruiting

Conditions: Healthy

Interventions: Other: 2500 ppm Carbon Dioxide
Other: 600 ppm Carbon Dioxide

First Posted Date: 2022-03-23

Last Posted Date: 2024-12-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 34

Registration Number: NCT05292378

Locations: 🇺🇸
Rutgers - EOHSI, Piscataway, New Jersey, United States

Opioid Analgesic Reduction Study (OARS) - Pilot

Phase 3

Completed

Conditions: Post Operative Pain

Interventions: Drug: OPIOID
Drug: NON-OPIOID

First Posted Date: 2022-03-17

Last Posted Date: 2023-06-06

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 53

Registration Number: NCT05283499

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
University of Illinois Chicago, Chicago, Illinois, United States

and more 2 locations

Immersive Virtual Reality Bicycling for Healthy Adults

Not Applicable

Completed

Conditions: Healthy

Interventions: Other: Virtual reality bicycling

First Posted Date: 2022-02-24

Last Posted Date: 2022-08-18

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 50

Registration Number: NCT05253703

Locations: 🇺🇸
Rutgers School of Health Professions, Newark, New Jersey, United States

Heart Rate Variability Biofeedback for Smoking Cessation Treatment

Phase 2

Completed

Conditions: Tobacco Smoking

Interventions: Behavioral: Cognitive-Behavioral Smoking Cessation
Biological: Heart Rate Variability Biofeedback
Drug: Nicotine patch

First Posted Date: 2022-02-04

Last Posted Date: 2024-05-01

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 28

Registration Number: NCT05224050

Locations: 🇺🇸
Rutgers, School of Arts and Sciences, One Spring Street, New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy